Recent developments in RNAi, particularly in the design of lentiviral-based short hairpin RNA (shRNA), now allow researchers to potentially develop diagnostic and prognostic strategies for treating cancer and metastasis.
03/11/2009
SCIENTISTS at the American National Cancer Institute have determined an important link between inherited factors and the progression of breast cancer into the metastatic stage during a recent study in mice.
14/01/2009
BAYER HealthCare has announced a global agreement with Ardea biosciences which will focus on the development of small molecule mitogen-activated ERK kinase (MEK) inhibitors for the treatment of solid tumours.
04/05/2009
PROGEN Pharmaceuticals Limited has announced new preclinical data on PG545, a dual antiangiogenic and anti-heparanase inhibitor, will be presented at an international cancer therapeutics conference.
15/10/2009
THE TRANSLATIONAL Genomics Research Institute (TGen) and Scottsdale Healthcare have announced two significant advances in treating lung cancer at the 13th World Conference on Lung Cancer in San Francisco.
11/08/2009
US researchers have shown how a microRNA, a short RNA molecule that regulates the activity of genes, called miR-9 may be important in a breast tumours’ ability to spread to other parts of the body and gather nutrients to survive and grow.
24/02/2010
RESEARCHERS using the Applied Biosystem developed SOLiD System have identified comprehensive profiles of gene activity from single cells, representing the first use of any next-generation genomic analysis platform for a hypothesis-neutral, genome-wide survey of expressed genes in individual cells.
14/04/2009
CIRCADIAN has been granted a key strategic patent for the exclusive use of the VEGF-D protein and VEGF-D antibodies in Europe for angiogenic applications.
23/06/2009
RESEARCHERS claim to have developed a mouse model that allows them to replicate normal pigment cells at the earliest stages of their conversion into malignant skin cancer in humans.
17/03/2009